---
figid: PMC5661630__sigtrans201729-f2
figtitle: Zinc deficiency in prostate cancer cells promotes cell survival via a phosphoinositide
  3-kinase (PI3K) signaling pathway
organisms:
- Mus musculus
- Rattus norvegicus
- Escherichia coli
- Mycobacterium tuberculosis variant bovis BCG
- Homo sapiens
- Danio rerio
- prion
- Aspergillus niger
pmcid: PMC5661630
filename: sigtrans201729-f2.jpg
figlink: /pmc/articles/PMC5661630/figure/fig2/
number: F2
caption: Zinc deficiency in prostate cancer cells promotes cell survival via a phosphoinositide
  3-kinase (PI3K) signaling pathway. Prostate cancer cells lack ZIP1 and PTEN. In
  zinc-deficient, PTEN-deficient conditions, PI3K is stimulated, leading to phosphorylation
  of protein kinase B (Akt) via phosphoinositide-dependent kinase (PDK). p-Akt then
  phosphorylates the cyclin-dependent kinase inhibitor p21. Phosphorylated p21 is
  retained in the cytoplasm where it may affect the cell cycle activity of the cyclin
  D/cyclin-dependent kinase 4 (CDK4) complex. In addition, the lack of nuclear p21
  may prevent activation of the PCNA, which normally prevents DNA synthesis during
  cell cycle progression. Thus, zinc deficiency affects p21 signaling pathways, leading
  to cell proliferation in prostate cancer cells.
papertitle: The emerging role of zinc transporters in cellular homeostasis and cancer.
reftext: Elizabeth Bafaro, et al. Signal Transduct Target Ther. 2017;2:17029.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.962107
figid_alias: PMC5661630__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Mus musculus
redirect_from: /figures/PMC5661630__F2
ndex: aafaa099-deda-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5661630__sigtrans201729-f2.html
  '@type': Dataset
  description: Zinc deficiency in prostate cancer cells promotes cell survival via
    a phosphoinositide 3-kinase (PI3K) signaling pathway. Prostate cancer cells lack
    ZIP1 and PTEN. In zinc-deficient, PTEN-deficient conditions, PI3K is stimulated,
    leading to phosphorylation of protein kinase B (Akt) via phosphoinositide-dependent
    kinase (PDK). p-Akt then phosphorylates the cyclin-dependent kinase inhibitor
    p21. Phosphorylated p21 is retained in the cytoplasm where it may affect the cell
    cycle activity of the cyclin D/cyclin-dependent kinase 4 (CDK4) complex. In addition,
    the lack of nuclear p21 may prevent activation of the PCNA, which normally prevents
    DNA synthesis during cell cycle progression. Thus, zinc deficiency affects p21
    signaling pathways, leading to cell proliferation in prostate cancer cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DOCK6
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - PDK1
  - PDK2
  - PDK3
  - PDK4
  - AKT1
  - AKT2
  - AKT3
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - CDK4
  - PCNA
  - Pik3cg
  - Pten
  - Akt1
  - Kras
  - Cdk4
  - Defb1
  - Pcna
  - Pik3r1
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
---
